NCT00715442 - Pre-Surgical Sutent in Renal Cell Carcinoma (RCC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 24, 2008

Primary Completion Date

December 4, 2026

Study Completion Date

December 4, 2026

Conditions

Renal Cell Carcinoma

Interventions

DRUG

Sunitinib

50 mg by mouth daily for 28 consecutive days

PROCEDURE

Nephrectomy

Nephrectomy will occur approximately 24 hours after the last dose of sunitinib.

Trial Locations (2)

Baylor College of Medicine, Houston

University of Texas MD Anderson Cancer Center, Houston